1. Home
  2. VKTX vs VC Comparison

VKTX vs VC Comparison

Compare VKTX & VC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • VC
  • Stock Information
  • Founded
  • VKTX 2012
  • VC 2000
  • Country
  • VKTX United States
  • VC United States
  • Employees
  • VKTX N/A
  • VC N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • VC Auto Parts:O.E.M.
  • Sector
  • VKTX Health Care
  • VC Consumer Discretionary
  • Exchange
  • VKTX Nasdaq
  • VC Nasdaq
  • Market Cap
  • VKTX 3.5B
  • VC 3.0B
  • IPO Year
  • VKTX 2015
  • VC 2000
  • Fundamental
  • Price
  • VKTX $26.98
  • VC $125.13
  • Analyst Decision
  • VKTX Strong Buy
  • VC Buy
  • Analyst Count
  • VKTX 13
  • VC 12
  • Target Price
  • VKTX $86.92
  • VC $116.10
  • AVG Volume (30 Days)
  • VKTX 9.7M
  • VC 283.9K
  • Earning Date
  • VKTX 10-22-2025
  • VC 10-23-2025
  • Dividend Yield
  • VKTX N/A
  • VC 0.88%
  • EPS Growth
  • VKTX N/A
  • VC N/A
  • EPS
  • VKTX N/A
  • VC 10.51
  • Revenue
  • VKTX N/A
  • VC $3,822,000,000.00
  • Revenue This Year
  • VKTX N/A
  • VC $0.78
  • Revenue Next Year
  • VKTX N/A
  • VC $3.52
  • P/E Ratio
  • VKTX N/A
  • VC $11.92
  • Revenue Growth
  • VKTX N/A
  • VC N/A
  • 52 Week Low
  • VKTX $18.92
  • VC $65.10
  • 52 Week High
  • VKTX $81.73
  • VC $128.32
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 41.03
  • VC 64.04
  • Support Level
  • VKTX $26.13
  • VC $122.34
  • Resistance Level
  • VKTX $28.26
  • VC $128.32
  • Average True Range (ATR)
  • VKTX 1.63
  • VC 2.71
  • MACD
  • VKTX -0.39
  • VC -0.49
  • Stochastic Oscillator
  • VKTX 19.82
  • VC 64.75

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About VC Visteon Corporation

Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.

Share on Social Networks: